09:00 AM·Business
Pharma Giant Lonza Sells Capsules Division to UK Firm for CHF 2.3 Billion
The Basel-based pharmaceutical supplier Lonza is selling its capsules and health ingredients business to British private equity firm Lone Star Funds in a deal expected to complete in the second half of 2026.
SWI swissinfo.ch
